Neurocrine Bioscienc
(NBIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 89,600 | 96,900 | 74,400 | 32,100 | 407,300 |
| Depreciation Amortization | 35,600 | 20,800 | 13,600 | 6,700 | 30,000 |
| Income taxes - deferred | 4,300 | 9,000 | 3,300 | -6,200 | -310,700 |
| Accounts receivable | -28,400 | -6,700 | -1,400 | 9,300 | -30,500 |
| Other Working Capital | 16,700 | 11,800 | 32,800 | 19,900 | -37,900 |
| Other Operating Activity | 138,700 | 120,500 | 67,800 | 25,500 | 170,300 |
| Operating Cash Flow | $256,500 | $252,300 | $190,500 | $87,300 | $228,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -102,200 | -658,700 | -18,900 | -93,700 | -735,500 |
| PPE Investments | -23,400 | -14,500 | -8,800 | -4,500 | -10,900 |
| Purchase Of Investment | -4,600 | -4,600 | N/A | N/A | N/A |
| Sale Of Investment | N/A | 523,900 | N/A | 161,300 | 750,500 |
| Investing Cash Flow | $-130,200 | $-153,900 | $-27,700 | $63,100 | $4,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -100 | N/A | -186,900 |
| Debt Repayment | -100 | -100 | N/A | -100 | N/A |
| Common Stock Issued | 27,500 | 25,700 | 18,200 | 15,200 | 29,100 |
| Financing Cash Flow | $27,400 | $25,600 | $18,100 | $15,100 | $-157,800 |
| Beginning Cash Position | 190,300 | 190,300 | 190,300 | 190,300 | 115,500 |
| End Cash Position | 344,000 | 314,300 | 371,200 | 355,800 | 190,300 |
| Net Cash Flow | $153,700 | $124,000 | $180,900 | $165,500 | $74,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 256,500 | 252,300 | 190,500 | 87,300 | 228,500 |
| Capital Expenditure | -23,400 | -14,500 | -8,800 | -4,500 | -10,900 |
| Free Cash Flow | 233,100 | 237,800 | 181,700 | 82,800 | 217,600 |